Variation in the PTEN-induced putative kinase 1 gene associated with the increase risk of type 2 diabetes in northern Chinese

Journal of Genetics

Volumn 90, Issue 1, 2011, Pages 125-128

  Qu, Yanchun ^a   Sun, Liang ^b   Yang, Ze ^b   Han, Ruifa ^a  

^a SECOND HOSPITAL OF TIANJIN MEDICAL UNIVERSITY   (China)

^b BEIJING HOSPITAL   (China)

Author keywords

case control studies; human genetics; polymerase chain reaction restriction fragments length polymorphism; PTEN induced putative kinase 1; type 2 diabetes mellitus

Indexed keywords

PROTEIN KINASE; PTEN INDUCED PUTATIVE KINASE; PTEN-INDUCED PUTATIVE KINASE;

ARTICLE; BODY MASS; BODY WEIGHT; CASE CONTROL STUDY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENETICS; GENOTYPE; HUMAN; MALE; METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS; POINT MUTATION;

BODY MASS INDEX; BODY WEIGHT; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC VARIATION; GENOTYPE; HUMANS; MALE; POINT MUTATION; PROTEIN KINASES;

EID: 79960085087     PISSN: 00221333     EISSN: 09737731     Source Type: Journal    
DOI: 10.1007/s12041-011-0020-y     Document Type: Article

References (13)

1. American Diabetes Association 2005 Standards of medical care in diabetes. Diabetes Care28, Suppl. 1, S4-S36.
2. Brooks J., Ding J., Simon-Sanchez J., Paisan-Ruiz C., Singleton A. B. and Scholz S. W. 2009 Parkin and PINK1 mutations in early-onset Parkinson's disease: comprehensive screening in publicly available cases and control. J. Med. Genet. 46, 375-381.
3. Chen F. J., Yu H., Fan F. and Lu J. X. 2009 Mitochondrial D-Loop gene polymorphisms in the patients with type 2 diabetes mellitus. Yi Chuan31, 265-272.
4. Choi J. M., Woo M. S., Ma H. I., Kang S. Y., Sung Y. H., Yong S. W. et al. 2008 Analysis of PARK genes in a Korean cohort of early-onset Parkinson disease. Neurogenetics9, 263-269.
5. Gandhi S., Wood-Kaczmar A., Yao Z., Plun-Favreau H., Deas E., Klupsch K. et al. 2009 PINK1-associated Parkinson's disease is caused by neuronal vulnerability to calcium-induced cell death. Mol. Cell33, 627-638.
6. Groen J. L., Kawarai T., Toulina A., Rivoiro C., Salehi-Rad S., Sato C. et al. 2004 Genetic association study of PINK1 coding polymorphisms in Parkinson's disease. Neurosci. Lett. 372, 226-229.
7. Kumazawa R., Tomiyama H., Li Y., Imamichi Y., Funayama M., Yoshino H. et al. 2008 Mutation analysis of the PINK1 gene in 391 patients with Parkinson disease. Arch. Neurol. 65, 802-808.
8. Lee H. J., Ryu H. J., Shin H. D., Park B. L., Kim J. Y., Cho Y. M. et al. 2008 Associations between polymorphisms in the mitochondrial uncoupling proteins (UCPs) with T2DM. Clin. Chim. Acta398, 27-33.
9. Nakamura Y., Kakoki M. and Yamakado M. 1996 The effect of age on glucose tolerance and plasma insulin level in hypertensive and normotensive subjects. Hypertens Res. 19, S23-S26.
10. Scheele C., Nielsen A. R., Walden T. B., Sewell D. A., Fischer C. P., Brogan R. J. et al. 2007 Altered regulation of the PINK1 locus: a link between type 2 diabetes and neurodegeneration? FASEB J. 21, 3653-3665.
11. Sun L., Yang Z., Jin F., Zhu X. Q., Qu Y. C., Shi X. H. and Wang L. 2006 The Gly482Ser variant of the PPARGC1 gene is associated with Type 2 diabetes mellitus in northern Chinese, especially men. Diabet. Med. 23, 1085-1092.
12. Toft M., Myhre R., Pielsticker L., White L. R., Aasly J. O. and Farrer M. J. 2007 PINK1 mutation heterozygosity and the risk of Parkinson's disease. J. Neurol., Neurosurg. Psychiatry78, 82-84.
13. Valente E. M., Abou-Sleiman P. M., Caputo V., Muqit M. M. K., Harvey K., Gispert S. et al. 2004 Hereditary early-onset Parkinson's disease caused by mutations in PINK1. Science304, 1158-1160.